Table 4.
Group | n | CEA | CA19-9 | ||
---|---|---|---|---|---|
|
|
||||
Before treatment | After treatment | Before treatment | After treatment | ||
OG | 30 | 45.4±7.66 | 24.5±3.58 | 72.1±12.13 | 50.1±12.25 |
CG | 30 | 43.2±8.43 | 9.3±1.62 | 75.4±15.93 | 31.4±5.69 |
t | 0.884 | 4.245 | 0.821 | 6.428 | |
P | 0.521 | <0.001 | 0.416 | <0.001 |
CG: control group; OG: observation group; CEA: carcinoembryonic antigen.